The AI-driven ‘endo-histo-omics’ approach integrates clinical, endoscopic, histological and molecular data to improve management of inflammatory bowel disease. This strategy enables precise patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback